ArticleBMC nephrology2026
Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysis.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFabry disease (FD) is an X-linked lysosomal storage disorder where early diagnosis is crucial to prevent irreversible organ damage. However, diagnosis is often delayed due to heterogeneous clinical presentations, particularly in heterozygous females and subjectively asymptomatic patients. Urinary mulberry cells and bodies are pathognomonic markers of FD, reflecting globotriaosylceramide (Gb3) accumulation in podocytes and consequent podocyte injury. Despite their diagnostic utility, these subtle morphological features are frequently missed by modern automated urine sediment analyzers and routine manual microscopy performed without specific clinical suspicion of FD. We emphasize the importance of "targeted" manual urine sediment examination triggered by clinical awareness. CASE PRESENTATION: We report a three-generation Japanese family with FD where targeted manual urine sediment examination served as the pivotal cue for diagnosis. The index case, a 61-year-old woman, was referred for incidental electrocardiographic abnormalities suspicious for left ventricular hypertrophy and trace proteinuria. Initial screening with an automated urine sediment analyzer and standard routine microscopy yielded non-specific findings. However, the revelation of a family history of FD during the clinical interview prompted a targeted manual re-evaluation of the urine sediment. This focused review successfully identified characteristic mulberry cells and bodies, triggering the genetic confirmation of a pathogenic GLA variant (c.761_763del). Subsequent screening of her subjectively asymptomatic 32-year-old daughter and 7-year-old grandson initially showed negative results on automated and routine non-targeted microscopy; however, targeted manual review revealed mulberry cells and bodies in the daughter and mulberry bodies in the grandson. These findings provided a compelling rationale for genetic testing in these subjectively asymptomatic relatives, confirming the diagnosis. Furthermore, urinary mulberry cell counts correlated with disease severity across the three family members and decreased following enzyme replacement therapy in the index case, paralleling the reduction in plasma lyso-Gb3.
conclusionsThis family illustrates that laboratory automation and routine non-targeted microscopy may have limitations in detecting Fabry nephropathy. Clinical awareness-the conscious suspicion of FD-serves as the decisive trigger for performing targeted manual urine sediment examination. Close communication between clinicians and laboratory technologists may be beneficial for identifying subtle diagnostic clues like mulberry cells and bodies that automated systems might overlook, ensuring early diagnosis and timely therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.